Aleksandr K. Rabinovich - La Jolla CA Dale S. Dhanoa - Del Mar CA David R. Luthin - San Diego CA Richard A. Bychowski - Cardiff CA Dilip R. Bhumralkar - San Diego CA
Assignee:
Alanex Corporation - San Diego CA
International Classification:
C07D40302 A61K 31495
US Classification:
514250
Abstract:
Benzo(e)perimidine-4-carboxamide derivatives of general structural formula I ##STR1## (where R. sub. a, R. sup. 1, R. sup. 2, R. sup. 3, R. sup. 4, R. sup. 5, and R. sup. 6 are as defined in the specification) have activity for receptors of corticotropin releasing factor (CRF). The compounds are useful in treating stress-related diseases, cardiovascular, neurological and psychiatric disorders including anxiety, depression, eating disorders, anorexia nervosa, superanuclear palsy, irritable bowel syndrome, gastrointestinal diseases, immune suppression, inflammatory disorders, drug and alcohol withdrawal symptoms, drug addiction, Alzheimer's disease or fertility disorders.
- Hoofddorp, NL Guangcheng JIANG - San Diego CA, US Aleksandr K. RABINOVICH - La Jolla CA, US
International Classification:
C07K 7/06 A61K 38/00
Abstract:
This disclosure relates to compounds of formula (I) or a pharmaceutically acceptable salt thereof: in which m, p, A, Ar, Ar, Ar, R, R, and Rare defined in the specification. The compounds of formula (I) can be used as CGRP antagonists and can be used to treat